Navigation Links
RiverVest Venture Partners Sells Four Successful Life Science Companies for More than $1 Billion
Date:2/6/2012

elping them achieve near-term objectives that position their companies for exit.

Since its inception in September 2000, RiverVest has raised two investment funds, with total committed capital of $164 million, and supported more than 25 innovative life science companies. For more information, please visit http://www.rivervest.com.

Media Contact
Callaway Zuccarello
Callaway  & Company
314-862-4300
callaway@callawayandco.com

[i] http://www.cambridgeassociates.com/pdf/Venture%20Capital%20Index.pdf, pp. 24-28 (Cambridge Associates' most recent Venture Capital Index, Sept. 30, 2011)


'/>"/>
SOURCE RiverVest Venture Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. John McKearn, Ph.D., Promoted to Managing Director of RiverVest Venture Partners
2. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
3. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
4. Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
5. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
6. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
7. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
8. MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital
9. Calvert Research and Auburn University Announce Joint Venture
10. Genomas to Present at Life Sciences & Healthcare Venture Summit
11. Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... dental biomaterial market will grow moderately through 2023 as ... and growing awareness of dental biomaterials all spur procedure ... such as China and ... bring dental procedures within reach for a larger proportion ...
(Date:12/17/2014)... The Activated Carbon Manufacturing industry ... IBISWorld updated its original industry research report. , ... intensified focus on environmental policy. Over the five years ... power plants and a range of other industrial facilities ... Sarah Kahn, “a range of downstream industrial sectors rely ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... ... its Scientific Advisory Board , ... Westlake Village, Calif. (PRWEB) October 9, 2009 -- Nanogea, a nano-biotech company focused on commercializing ... C. Thomas Caskey and Dr. Saul Tendler have joined its scientific advisory board. , ...
... 8 CardioDx, a cardiovascular genomic diagnostics company, announced ... as Chairman of the company,s Board of Directors. CardioDx ... expression test to quantify the likelihood of obstructive(1) coronary ... , "Dr. Lange brings an ideal perspective to ...
... ... completely noninvasive, biometric health evaluation system designed for ordinary people who want to proactively monitor ... ... is the first of its kind, fully automated, and completely noninvasive, biometric health evaluation system ...
Cached Biology Technology:Nanogea Announces New Scientific Advisory Board Members 2Nanogea Announces New Scientific Advisory Board Members 3CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors 2CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors 3IridoTech Announces IridoLab Self Service Kiosk 2
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... cases, scientists at Johns Hopkins have discovered the genetic origins ... the leading reason for corneal transplantation in the United States. ... the cells covering the clear, outermost lens of the eye ... Late in life, the dystrophy causes swelling of the cornea ...
... by the sleek and efficient propulsion of squid, jellyfish ... researcher has designed a new generation of compact vortex ... maneuver and dock underwater vehicles at low speeds and ... seemingly inspired by the plots of two classic sci-fi ...
... pregnant woman will give birth to a child with Down Syndrome ... Although it is a fact that as women get older, they ... factors also play a role. According to Markus Neuhäuser and ... at University Hospital Essen, in Germany, the risk of a child ...
Cached Biology News:Leading reason for corneal transplants comes into focus 2Leading reason for corneal transplants comes into focus 3Squid-inspired design could mean better handling of underwater vehicles 2Down syndrome: It's not just the age factor 2
... analysis of gene expression) technology ... Expression profiles generated by SAGE ... low-abundance transcripts making it possible ... I-SAGE Kit is designed to ...
Mycoplasma tested...
... SAGE (serial analysis of gene ... expression analysis. Expression profiles generated ... to detect low-abundance transcripts making ... genes. The I-SAGE Kit is ...
Human LAIR2 Biotinylated Affinity Purified PAb...
Biology Products: